Science Applications International Corporation SAIC
132.61
0.18
0.14%
as of 25 Sep
- Market cap
- $5.6B
- P/E
- 15.4×
Follow SAIC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.57 | 10.82 | 13.03 | 11.91 |
+8 more quarters Free account |
P/S ratio |
0.67 | 0.58 | 0.64 | 0.59 | |
P/FCF ratio |
8.02 | 7.01 | 8.09 | 10.07 | |
P/Operating CF |
34.02 | 33.30 | 18.10 | 33.34 | |
P/B ratio |
3.46 | 2.97 | 3.11 | 2.84 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.99 | 0.91 | 0.96 | 0.92 | |
EV/EBITDA |
9.78 | 9.02 | 10.41 | 10.05 | |
EV/Operating CF |
11.10 | 10.39 | 11.45 | 14.47 | |
EV/FCF |
11.83 | 10.96 | 12.09 | 15.79 | |
Quick Ratio |
1.06 | 1.03 | 1.05 | 1.04 | |
Current Ratio |
1.20 | 1.16 | 1.20 | 1.20 | |
Net Debt/EBITDA |
12.35 | 10.85 | 13.32 | 14.71 | |
Debt/Assets |
45.82% | 46.57% | 46.45% | 45.86% | |
Debt/Equity |
1.73 | 1.75 | 1.66 | 1.64 | |
Asset Turnover |
1.39 | 1.38 | 1.37 | 1.37 | |
Operating CF/Net income |
1.43 | 1.10 | 3.04 | 1.65 | |
Capex/Depreciation |
(0.38) | (0.22) | (0.20) | (0.24) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
4.63% | 4.35% | 4.86% | 5.41% | |
Intangible Assets out of Total Assets |
0.67 | 0.69 | 0.69 | 0.69 | |
Share Based Compensation of Revenue |
0.80% | 0.68% | 0.74% | 1.39% | |
Graham Net Nets |
(0.55) | (0.64) | (0.57) | (0.62) | |
Graham Number |
81.09 | 80.93 | 75.11 | 76.37 | |
Earnings Yield |
7.37% | 9.24% | 7.67% | 8.40% | |
Free Cash Flow Yield |
12.46% | 14.26% | 12.35% | 9.93% | |
Revenue per Share |
44.34 | 43.62 | 37.80 | 40.65 | |
Operating CF per Share |
3.44 | 2.91 | 5.57 | 2.81 | |
Capex per Share |
(0.35) | (0.21) | (0.17) | (0.20) | |
Free Cash Flow per Share |
3.09 | 2.70 | 5.40 | 2.61 | |
Cash per Share |
2.97 | 2.49 | 3.93 | 0.98 | |
Shareholders Equity per Share |
33.87 | 32.56 | 32.40 | 32.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
33.87 | 32.56 | 32.40 | 32.94 | |
Free Cash Flow |
131.00 | 118.00 | 250.00 | 120.00 | |
Working Capital |
217.00 | 162.00 | 197.00 | 207.00 | |
Capital Expenditures |
(15.00) | (9.00) | (8.00) | (9.00) | |
Net Current Asset Value |
(2,708.00) | (2,716.00) | (2,675.00) | (2,654.00) | |
EV/EBIT |
12.37 | 11.41 | 13.39 | 12.82 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
5.43% | 6.03% | 4.86% | 4.18% | |
Price to Operating Income |
8.39 | 7.30 | 8.97 | 8.18 | |
| Other line items | |||||
Average Receivables |
973.50 | 985.50 | 926.50 | 1,033.50 | |
Average Payables |
577.00 | 651.00 | 565.50 | 670.50 | |
Average Assets |
5,312.00 | 5,274.50 | 5,300.00 | 5,349.00 | |
Average Common Equity |
1,476.50 | 1,464.00 | 1,538.50 | 1,562.00 |
Columns are period end dates